News & Events

News Releases

Month Year

Month Year

Investor Alerts

May 3, 2002

DaVita Inc. Announces Extension of Expiration Date of the Tender Offer for Its Common Shares
May 2, 2002

DaVita Announces Development Concerning the Company's Florida Laboratory
Apr 29, 2002

Amgen Raises EPOGEN Pricing
Apr 26, 2002

DaVita Announces Closing of Note Tender Offer
Apr 23, 2002

DaVita Revises Purchase Price in Tender Offer and Consent Solicitation for Its 9.25% Senior Subordinated Notes Due 2011

Show per page